Nomura Asset Management CO LTD Mersana Therapeutics, Inc. Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022
SELL
$5.48 - $9.86 $0 - $0
0 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$8.56 - $14.47 $0 - $0
0 New
0 $0
Q2 2021

Aug 06, 2021
BUY
$13.28 - $18.07 $0 - $0
0 New
0 $0
Q1 2021

May 14, 2021
BUY
$15.31 - $26.52 $0 - $0
0 New
0 $0
Q4 2020

Feb 12, 2021
BUY
$16.84 - $27.59 $0 - $0
0 New
0 $0
Q3 2020

Nov 12, 2020
BUY
$16.2 - $25.7 $0 - $0
0 New
0 $0
Q2 2020

Aug 13, 2020
BUY
$5.24 - $23.4 $0 - $0
0 New
0 $0

Others Institutions Holding MRSN

# of Institutions
121
Shares Held
116M
Call Options Held
233K
Put Options Held
457K
View Full List

About Mersana Therapeutics, Inc.

MRSN Quotes by TradingView
  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $198M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email